Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check3 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the record history. The HHS Vulnerability Disclosure and Revision: v3.3.2 elements were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.2; Removed Revision: v3.2.0 from the history.SummaryDifference0.1%

- Check39 days agoChange DetectedA site-wide government funding notice banner appears, indicating that information may not be up to date and that operations may be affected; it directs users to cc.nih.gov for operating status and opm.gov for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check53 days agoChange DetectedUpdated study status is shown on the history page. Additional sections such as Adverse Events and Outcome Measures have been revised, reflecting ongoing updates to the NCT04098068 trial record.SummaryDifference0.1%

- Check82 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference11%

- Check89 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.